🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase I, multicentre, single-dose, open-label study to assess the...
Status
Not Yet Recruiting
Location
Research Site
Start Date
2026-06-30
Trial ID
NCT07643870
Treatments Being Tested
The purpose of this study is to find out whether AZD1390 combined with ster...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Monmouth (All Protocol Activities)
Start Date
2023-05-17
Trial ID
NCT05678010
Treatments Being Tested
This phase I clinical trial studies the side effects and best dose of AZD13...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Start Date
2025-06-18
Trial ID
NCT06894979
CONCORDE is a multi-institution, multi-arm, Phase IB study that will determ...
Status
Recruiting
Location
Belfast City Hospital
Start Date
2021-03-17
Trial ID
NCT04550104
Treatments Being Tested
Glioblastoma (GBM) adaptive, global, innovative learning environment (GBM A...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2019-07-30
Trial ID
NCT03970447
This is an open-label, single-center Phase 0/1b study that will enroll at l...
Status
Active Not Recruiting
Location
St. Joseph's Hospital and Medical Center
Start Date
2022-05-27
Trial ID
NCT05182905
Treatments Being Tested
To assess the safety and tolerability profile, in the pre- and perioperativ...
Status
Terminated
Location
Antoni van Leeuwenhoek
Start Date
2022-07-18
Trial ID
NCT05116254
Treatments Being Tested
This is an open-label, single centre exploratory study to analyse brain exp...
Status
Completed
Location
Research Site
Start Date
2017-10-10
Trial ID
NCT03215381
Treatments Being Tested
This study will test an investigational drug called AZD1390 in combination ...
Status
Active Not Recruiting
Location
Research Site
Start Date
2018-04-02
Trial ID
NCT03423628
Treatments Being Tested